Henry Schein Inc. (NASDAQ:HSIC) – Research analysts at William Blair boosted their Q4 2016 earnings per share estimates for shares of Henry Schein in a research note issued on Monday. William Blair analyst J. Kreger now forecasts that the firm will post earnings of $1.87 per share for the quarter, up from their previous estimate of $1.86.
HSIC has been the topic of several other research reports. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, July 5th. Bank of America Corp. assumed coverage on shares of Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price target on the stock. Robert W. Baird reiterated an “outperform” rating and set a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective on the stock in a research note on Tuesday. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Henry Schein currently has an average rating of “Hold” and an average target price of $159.50.
Shares of Henry Schein (NASDAQ:HSIC) opened at 156.05 on Thursday. The stock has a market cap of $12.76 billion, a price-to-earnings ratio of 26.44 and a beta of 1.05. Henry Schein has a 1-year low of $142.64 and a 1-year high of $183.00. The firm has a 50-day moving average of $162.38 and a 200 day moving average of $170.17.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Thursday, August 4th. The company reported $1.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.63 by $0.01. The firm earned $2.87 billion during the quarter, compared to analyst estimates of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter last year, the business posted $1.46 EPS.
Hedge funds have recently made changes to their positions in the stock. Ngam Advisors L.P. acquired a new stake in shares of Henry Schein during the first quarter worth approximately $1,749,000. TIAA CREF Investment Management LLC boosted its stake in shares of Henry Schein by 5.8% in the first quarter. TIAA CREF Investment Management LLC now owns 296,985 shares of the company’s stock worth $51,269,000 after buying an additional 16,247 shares in the last quarter. Carnick & Kubik LLC acquired a new stake in shares of Henry Schein during the first quarter worth approximately $1,447,000. Meiji Yasuda Asset Management Co Ltd. boosted its stake in shares of Henry Schein by 60.0% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,586 shares of the company’s stock worth $446,000 after buying an additional 970 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in shares of Henry Schein by 214.1% in the first quarter. Canada Pension Plan Investment Board now owns 26,101 shares of the company’s stock worth $4,506,000 after buying an additional 17,791 shares in the last quarter. 91.98% of the stock is owned by institutional investors and hedge funds.
In related news, Director Paul Brons sold 3,381 shares of the stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now owns 13,715 shares in the company, valued at $2,249,671.45. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.